Autologous tumor cells engineered for immune system stimulation can target unique metabolic, genomic, and phenotypic characteristics of cancer cells.
Terry Opgenorth
Advertisement
Terry Opgenorth, PhD, is the executive in residence life sciences for CSU Ventures.
Articles by Terry Opgenorth
Advertisement
Latest Updated Articles
Advertisement
Advertisement